Limbach Holdings, Inc. (Nasdaq: LMB), a prominent firm specializing in building systems solutions, has appointed David Gaboury to its Board of Directors. Mr. Gaboury, a seasoned industry leader with over 40 years of experience in engineering, joins Limbach’s Board, which now comprises seven directors, six of whom are independent. Previously serving as Board Chair, CEO, and President of Terracon, where he significantly grew annual revenue and elevated the firm’s industry ranking, Mr. Gaboury currently holds the position of Chair Emeritus at Terracon. Before Terracon, he held senior roles at Woodward-Clyde Consultants, culminating in his tenure as COO and President.
Beyond his corporate achievements, Mr. Gaboury has contributed extensively to various boards and organizations, including Smith Seckman Reid, RS&H, Weston Solutions, Inc., and Hall’s Culligan. His leadership extends to roles such as Chair of the Board of Trustees for Olathe Medical Center, Inc. and participation in the Construction Industry Round Table and ACE Mentor Program. He holds a B.S. degree in Civil Engineering from the University of Massachusetts Amherst and an M.S. degree from the Massachusetts Institute of Technology.
Mr. Gaboury succeeds Norbert W. Young, who retired after nearly eight years on the board. Joshua S. Horowitz, a board member since March 2020, assumes the role of Chairman of the Board effective June 13, 2024, succeeding Gordon G. Pratt, who transitions to Chairman Emeritus. Additionally, Linda G. Alvarado and Michael F. McNally will lead the Nominating & Governance Committee and Compensation Committee, respectively, as part of broader leadership adjustments aimed at leveraging diverse expertise.
I am pleased to welcome David to our Board of Directors, stated Joshua S. Horowitz, Chairman of the Board of Limbach Holdings. “His wealth of experience and strategic insight will bolster our efforts to excel as the premier provider of building systems solutions. We anticipate David’s contributions will significantly contribute to our overall growth and expansion plans.